Endothelin‐1 mediated inhibition of the acetylcholine‐activated potassium current from rabbit isolated atrial cardiomyocytes
Authors: Spiers J. Paul , Kelso Elizabeth J. , McDermott Barbara J. , Scholfield C. Norman , Silke Bernard 
Published: July 2012

Endothelin‐1 is a 21 amino acid peptide with potent inotropic and chronotropic actions in the heart. Relatively little is known about the underlying electrophysiological effects of the peptide. In this study, the effects of endothelin‐1 (ET‐1) on the acetylcholine‐activated potassium current (IK(ACh)) were investigated in the absence and presence of the receptor‐selective antagonists, PD155080 (ETA receptor‐selective) and RES‐701 (ETB receptor‐selective) in rabbit atrial cardiomyocytes.
Cells were obtained from New Zealand White rabbits (2.5‐3 kg) by enzymatic dissociation with collagenase. Potassium currents were recorded, in the presence of nifedipine (μm), by use of the whole cell ruptured patch‐clamp technique. Following stabilization, control recordings were made with standard pulse protocols, and drugs were applied by a gravity fed microperfusion system.
Endothelin‐1 (10 nM) alone did not affect the ‘steady state’ potassium current. Acetylcholine (1μm) increased (P < 0.05) the potassium current to −1321 ± 290 pA, from a control value of −955 ± 191 pA, at a step potential of −100 mV. Acetylcholine also increased the holding current at −40 mV from + 80 ± 9 pA to +242 ± 38 pA, and this effect was abolished (P < 0.05) in the presence of endothelin‐1 (+ 44 ± 13 pA). The responses to acetylcholine were attributed to activation of the atrial muscarinic‐activated potassium current (IK(ACh)) as they were blocked by atropine (10 μm). Endothelin‐1 (10 nM) in the presence of acetylcholine did not affect the ‘steady state’ potassium current (−882 ± 88 pA compared to a control value of −870 ± 98 pA, at −100 mV).
The ETA receptor‐selective antagonist, PD155080 (1 μm), prevented (P < 0.05) the ET‐1 induced inhibition of IK(ACh) at all potentials. PD155080, in the presence of endothelin‐1 and acetylcholine, increased the inward component of the ‘steady state’ potassium current to −1030 ± 210 pA from a control value of −804 ± 224 pA at a step potential of −100 mV. Also the outward component was increased at a potential of −20 mV from +90 ± 17 pA to +241 ± 47 pA.
Unlike PD 155080, the ETB receptor‐selective antagonist, RES‐701 (1 μm), only prevented (P < 0.05) the inhibitory effect of endothelin‐1 on the inward component of the IK(ACh); at −100 mV, RES‐701, in the presence of endothelin‐1 and acetylcholine, increased the ‘steady state’ potassium current to −913 ± 137 pA from −733 ± 116 pA. Furthermore, RES‐701, in contrast to PD155080, failed to sustain this inhibitory effect as, in the presence of endothelin‐1 and acetylcholine, the ‘steady state’ potassium current returned to a value of −768 ± 96 pA, at a step potential of −100 mV.
In conclusion, endothelin‐1 clearly inhibits the effects of acetylcholine on IK(ACh) in rabbit atrial cardiomyocytes. This effect is primarily mediated by an ETA receptor‐subtype, but is transiently and partially mediated by a RES‐701‐sensitive ETB receptor subtype. Inhibition of the IK(ACh) may account for the positive chronotropic properties of endothelin‐1.